Pharmaceuticals

Global Menopausal Disorder Treatment Market Revenue and Share Analysis Through 2029

December 4, 2025 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the menopausal disorder treatment market from 2025–2034 with trusted insights from The Business Research Company

What Is The Projected Valuation Of The Menopausal Disorder Treatment Market In The Period 2029-2034?

The menopausal disorder treatment market size has seen significant growth in recent years. It is projected to expand from $10.69 billion in 2024 to $11.47 billion in 2025, achieving a compound annual growth rate (CAGR) of 7.3%. This historical growth can be attributed to an aging female population, increased awareness regarding menopause-related health issues, the high prevalence of obesity exacerbating menopausal symptoms, a growing acceptance of hormone replacement therapy (HRT), and the development of personalized medicine.

The menopausal disorder treatment market is projected for significant expansion over the coming years. This market is anticipated to reach $15.2 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 7.3%. Factors driving this growth during the forecast period include rising investment in healthcare infrastructure, a heightened focus on women’s health programs, increased partnerships between pharmaceutical firms and research bodies, and expanding urbanization contributing to lifestyle shifts affecting menopausal well-being. Key trends anticipated for this period encompass a move towards natural and herbal remedies, the incorporation of artificial intelligence into treatment strategies, the introduction of wearable technologies for live symptom tracking, an emphasis on comprehensive wellness programs for menopause, and boosted funding for women’s health startups developing menopause solutions.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24318&type=smp

What Strategic Drivers Are Accelerating The Menopausal Disorder Treatment Market Expansion?

The increasing need for hormone replacement therapies (HRT) is anticipated to boost the menopausal disorder treatment market in the coming years. HRT represents a medical approach focused on supplementing or replacing hormones to mitigate symptoms linked to menopause or hormonal imbalances. The surge in hormone replacement therapies results from heightened awareness and a desire for efficient management of menopausal indications and hormone irregularities. HRT addresses menopausal disorders by directly restoring estrogen and progesterone levels, thereby aiding in re-establishing hormonal equilibrium and alleviating problematic symptoms like hot flashes, night sweats, and mood swings, consequently enhancing overall quality of life. As an illustration, in October 2024, the NHS Business Services Authority (NHSBSA), a UK-based entity offering various support services, stated that the quantity of HRT items prescribed grew by 22% to 13 million, alongside a 12% rise in identified patients, moving from 2.3 million in 2022/23 to 2.6 million in 2023/24. Thus, the escalating demand for hormone replacement therapies is fostering the expansion of the menopausal disorder treatment market.

What Is The Detailed Segment Distribution Of The Menopausal Disorder Treatment Market?

The menopausal disorder treatment market covered in this report is segmented –

1) By Treatment Type: Hormone Replacement Therapy, Non-Hormonal Treatment, Herbal Supplements, Lifestyle Modifications

2) By Stages: Menopause, Postmenopause, Perimenopause

3) By Application: Hot Flashes, Night Sweats, Mood Swings, Vaginal Dryness

4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channels

5) By End-Users: Hospitals, Specialty Clinics, Homecare, Other End-Users

Subsegments:

1) By Hormone Replacement Therapy (HRT): Estrogen Therapy, Progesterone Therapy, Combination Therapy, Transdermal Patches, Vaginal Estrogen, Oral Tablets

2) By Non-Hormonal Treatment: Selective Estrogen Receptor Modulators (SERMs), Antidepressants, Gabapentin, Clonidine, Bisphosphonates, Calcium And Vitamin D Supplements

3) By Herbal Supplements: Black Cohosh, Red Clover, Dong Quai, Ginseng, Soy Isoflavones, Flaxseed

4) By Lifestyle Modifications: Dietary Changes, Regular Physical Exercise, Stress Management Techniques, Cognitive Behavioral Therapy (CBT), Smoking Cessation, Sleep Hygiene Practices

How Are Global Trends Impacting The Development Of The Menopausal Disorder Treatment Market?

Leading companies in the menopausal disorder treatment market are actively developing innovative nonhormonal neurokinin 3 (NK3) receptor antagonist drugs to effectively manage vasomotor symptoms without resorting to hormone therapy. These novel nonhormonal neurokinin 3 (NK3) receptor antagonist therapies work by blocking NK3 receptors, thereby alleviating menopausal symptoms without using hormones. For example, in December 2023, Astellas Pharma Inc., a Japan-based pharmaceutical company, secured European Commission approval for Veozah (fezolinetant), which is a non-hormonal NK3 receptor antagonist intended for treating moderate to severe vasomotor symptoms (VMS), including hot flashes and night sweats, in menopausal women. This treatment operates by targeting specific neurons within the brain’s temperature control center to diminish both the frequency and intensity of these symptoms.

Who Are The Major Stakeholders Operating In The Menopausal Disorder Treatment Market?

Major companies operating in the menopausal disorder treatment market are Pfizer Inc., F. Hoffmann-La Roche Ltd, Merck & Co Inc., Novartis AG, Bayer AG, Bristol-Myers Squibb Company, Sanofi SA, AstraZeneca plc, Eli Lilly and Company, Novo Nordisk A/S, Abbott Laboratories, GlaxoSmithKline plc, Teva Pharmaceutical Industries Ltd., Ipsen SA, Dr. Reddy’s Laboratories Ltd., Theramex, Besins Healthcare, Mithra Pharmaceuticals, Duchesnay USA, Fervent Pharmaceuticals, Joylux Inc., TherapeuticsMD Inc.

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/menopausal-disorder-treatment-global-market-report

Which Region Is Projected To Achieve The Fastest Growth In The Menopausal Disorder Treatment Market?

North America was the largest region in the menopausal disorder treatment market in 2024. The regions covered in the menopausal disorder treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=24318&type=smp

Browse Through More Reports Similar to the Global Menopausal Disorder Treatment Market 2025, By The Business Research Company

Menopausal Hot Flashes Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/menopausal-hot-flashes-global-market-report

Postmenopausal Osteoporosis Treatment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/postmenopausal-osteoporosis-treatment-global-market-report

Vasomotor Menopausal Symptoms Vms Treatment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/vasomotor-menopausal-symptoms-vms-treatment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795